StimCardio
Los Angeles, CA
- Neuromodulation
- Wearables
StimCardio is a clinical-stage medical device company developing non-invasive neuromodulation technologies for cardiovascular applications, initially focused on atrial fibrillation. Its Rhyvive wearable combines ECG and optical sensing, wrist-based stimulation, mobile connectivity, and cloud-based analysis to support personalized, physician-prescribed, at-home rhythm care.
What makes StimCardio distinct
- 01Integrates non-invasive neuromodulation, continuous physiological sensing, and adaptive intelligence in a single cardiovascular platform.
- 02Focuses on extending arrhythmia care beyond the clinic through physician-prescribed, at-home wearable therapy.
- 03Uses a closed-loop architecture designed to tailor stimulation based on longitudinal physiological patterns and individual responses.
- 04Combines expertise across cardiovascular medicine, neuromodulation, biomedical engineering, data science, clinical research, and medical device development.
- 05Has a modular platform strategy designed to support future cardiovascular and neuro-cardiac applications beyond atrial fibrillation.
Technology & products
- Rhyvive wearable wrist-based cardiac therapy device
- Median–vagus neuromodulation (mVNS)
- Closed-loop ECG and optical physiological sensing
- StimCardio Health Cloud for cloud-based physiological data aggregation and analysis
- Machine learning-enabled personalization and adaptive neuromodulation
- Companion mobile application with secure data transmission
In the Cortex
- CardiaCare Rebrands to StimCardio Medical for Neuromodulation FocusStimCardio on LinkedIn · Feb 4, 2026
Similar companies
About StimCardio
- Headquarters
- Los Angeles, CA